Clinical trial · Observational
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
Impact of Environmental Factors and Metabolomics on Colorectal Cancer Development and Prognosis Based on Environmental Factors and Metabolomics.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Colorectal cancer is one of the malignant tumours with high morbidity and mortality worldwide, posing a serious threat to human health. In recent years, the incidence of colorectal cancer has been on the rise with changes in lifestyle and dietary habits. Although some progress has been made in treatments such as surgery, chemotherapy and radiotherapy, however, the early diagnosis, prognosis assessment and personalised treatment of colorectal cancer still face great challenges. Therefore, it is of great academic value and practical significance to deeply explore the influencing factors of colorectal cancer occurrence, development and its prognosis, especially the research on environmental factors and metabolomics.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Metabolic Disease | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| colorectal cancer | Diagnostic Test | — | UNRESOLVED |
| colorectal neoplasm | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- the control group
- description
- Adults with no history of malignancy and willing to participate in this study.
- label
- the colorectal cancer group
- description
- Patients with preoperative diagnosis of colorectal cancer confirmed by pathological biopsy.
- interventionNames
- Diagnostic Test: colorectal cancer
- label
- the colorectal adenoma group
- description
- Patients with preoperative diagnosis of colorectal adenoma confirmed by colonoscopy.
- interventionNames
- Diagnostic Test: colorectal neoplasm
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Healthy control group: * age ≥18 years old; * no history of malignant tumour; * willing to participate in this study and sign the informed consent form; * complete basic data. 2. Gastric cancer group: * age ≥18 years old; * patients diagnosed with gastric cancer by pathological biopsy before operation; * no chemotherapy, radiotherapy, targeted and immunotherapy before enrolment; * willing to participate in this study and sign the informed consent; complete clinical data. Exclusion criteria: * patients with primary malignant tumours other than gastric cancer; * patients with serious cardiopulmonary insufficiency and other systemic diseases that affect the choice of treatment plan; * patients who are not suitable for enrolment as assessed by the investigator.
References
Publications (0)
Data not yet available